Clinical trial
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory…
NCT00328367 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00328367 |
|---|---|
| Title | Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia |
| Official title | A Double-Blind Randomized Placebo Controlled Study of Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia |
| Lead sponsor | Seoul National University Hospital, Other |
| Collaborators | Korea Otsuka Pharmaceutical Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | aripiprazole, placebo |
| Enrollment | 61 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | May 19, 2006 |
| Last update posted | Oct 29, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: